IL-9 is a susceptibility factor in Leishmania major infection by promoting detrimental Th2/Type 2 responses

Journal of Immunology

Volumn 174, Issue 4, 2005, Pages 2205-2211

  Arendse, Berenice ^a   Van Snick, Jacques ^b   Brombacher, Frank ^a,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DRUG EFFECT; DRUG MECHANISM; IMMUNE RESPONSE; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; VACCINATION;

EID: 13544250810     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.4.2205     Document Type: Article

References (33)

1. Uyttenhove, C., R. J. Simpson, and J. Van Snick. 1988. Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity. Proc. Natl Acad. Sci. USA 85:6934.
2. Renauld, J. C., F. Houssiau, J. Louahed, A. Vink, J. Van Snick, and C. Uyttenhove. 1993. Interleukin-9. Adv. Immunol. 54:79.
3. Demoulin, J. B., and J. C. Renauld. 1998. Interleukin 9 and its receptor: an overview of structure and function. Int. Rev. Immunol. 16:345.
4. Gessner, A., H. Blum, and M. Rollinghoff. 1993. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. Immunobiology 189:419.
5. Grencis, R. K., L. Hultner, and K. J. Else. 1991. Host protective immunity to Trichinella spiralis in mice: activation of Th cell subsets and lymphokine secretion in mice expressing different response phenotypes. Immunology 74:329.
6. Svetic, A., K. B. Madden, X. D. Zhou, P. Lu, I. M. Katona, F. D. Finkelman, J. F. Urban, Jr., and W. C. Gause. 1993. A primary intestinal helminthic infection rapidly induces a gut-associated elevation of Th2-associated cytokines and IL-3. J. Immunol. 150:3434.
7. Faulkner, H., J. C. Renauld, S. J. Van, and R. K. Grencis. 1998. Interleukin-9 enhances resistance to the intestinal nematode Trichuris muris. Infect. Immun. 66:3832.
8. Kopf, M., G. G. Le, M. Bachmann, M. C. Lamers, H. Bluethmann, and G. Koehler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245.
9. Monteyne, P., J. C. Renauld, B. J. Van, D. W. Dunne, F. Brombacher, and J. P. Coutelier. 1997. IL-4-independent regulation of in vivo IL-9 expression. J. Immunol. 159:2616.
10. Renauld, J. C., N. van der Lugt, A. Vink, M. van Roon, C. Godfraind, G. Warnier, H. Merz, A. Feller, A. Berns, and J. Van Snick. 1994. Thymic lymphomas in interleukin 9 transgenic mice. Oncogene 9:1327.
11. Vink, A., G. Warnier, F. Brombacher, and J. C. Renauld. 1999. Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population. J. Exp. Med. 189:1413.
12. Louahed, J., Y. Zhou, W. L. Maloy, P. U. Rani, C. Weiss, Y. Tomer, A. Vink, J. Renauld, J. Van Snick, N. C. Nicolaides, et al. 2001. Interleukin 9 promotes influx and local maturation of eosinophils. Blood 97:1035.
13. Faulkner, H., N. Humphreys, J. C. Renauld, J. Van Snick, and R. Grencis. 1997. Interleukin-9 is involved in host protective immunity to intestinal nematode infection. Eur. J. Immunol. 27:2536.
14. Temann, U. A., P. Ray, and R. A. Flavell. 2002. Pulmonary overexpression of 1L-9 induces Th2 cytokine expression, leading to immune pathology. J. Clin. Invest. 109:29.
15. Townsend, J. M., G. P. Fallon, J. D. Matthews, P. Smith, E. H. Jolin, and N. A. McKenzie. 2000. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 13:573.
16. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of interferon-γ or interleukin 4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169:59.
17. Louis, J., H. Himmelrich, L. C. Parra, C. F. Tacchini, and P. Launois. 1998. Regulation of protective immunity against Leishmania major in mice. Curr. Opin. Immunol. 10:459.
18. Fowell, D. J., and R. M. Locksley. 1999. Leishmania major infection of inbred mice: unmasking genetic determinants of infectious diseases. BioEssays 21:510.
19. Brombacher, F. 2000. The role of interleukin-13 in infectious diseases and allergy. BioEssays 22:646.
20. Nashed, B. F., Y. Maekawa, M. Takashima, T. Zhang, K. Ishii, T. Dainichi, H. Ishikawa, T. Sakai, H. Hisaeda, and K. Himeno. 2000. Different cytokines are required for induction and maintenance of the Th2 type response in DBA/2 mice resistant to infection with Leishmania major. Microbes Infect. 2:1435.
21. Richard, M., R. K. Grencis, N. E. Humphreys, J. C. Renauld, and J. Van Snick. 2000. Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice. Proc. Natl. Acad. Sci. USA 97:767.
22. Mohrs, M., B. Ledermann, G. Kohler, A. Dorfmuller, A. Gessner, and F. Brombacher. 1999. Differences between IL-4- and 1L-4 receptor α-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling. J. Immunol. 162:7302.
23. Landegren, U. 1984. Measurement of cell numbers by means of the endogenous enzyme hexosaminidase: applications to detection of lymphokines and cell surface antigens. J. Immunol. Methods 67:379.
24. Mohrs, M., C. Holscher, and F. Brombacher. 2000. Interleukin-4 receptor α-deficient BALB/c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection. Infect. Immun. 68:1773.
25. Herbert, D. R., C. Holscher, M. Mohrs, B. Arendse, A. Schwegmann, M. Radwanska, M. Leeto, R. Kirsch, P. Hall, H. Mossmann, et al. 2004. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20:623.
26. Druez, C., P. Coulie, C. Uyttenhove, and J. Van Snick. 1990. Functional and biochemical characterization of mouse P40/IL-9 receptors. J. Immunol 145:2494.
27. Lemesre, J. L., D. Sereno, S. Daulouede, B. Veyret, N. Brajon, and P. Vincendeau. 1997. Leishmania spp.: nitric oxide-mediated metabolic inhibition of promastigote and axenically grown amastigote forms. Exp. Parasitol. 86:58.
28. Hesse, M., M. Modolell, A. C. La Flamme, M. Schito, J. M. Fuentes, A. W. Cheever, E. J. Pearce, and T. A. Wynn. 2001. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol 167:6533.
29. Stenger, S., H. Inuring, M. Rollinghoff, and C. Bogdan. 1994. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180:783.
30. Wei, X. Q., I. G. Charles, A. Smith, J. Ure, G. J. Feng, F. P. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408.
31. Roberts, S. C., M. J. Tancer, M. R. Polinsky, K. M. Gibson, O. Heby, and B. Ullman. 2004. Arginase plays a pivotal role in polyamine precursor metabolism in Leishmania: characterization of gene deletion mutants. J. Biol. Chem. 279:23668.
32. Iniesta, V., L. C. Gomez-Nieto, I. Molano, A. Mohedano, J. Carcelen, C. Miron, C. Alonso, and I. Corraliza. 2002. Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites. Parasite Immunol. 24:113.
33. Grohmann, U., J. Van Snick, F. Campanile, S. Silla, A. Giampietri, C. Vacca, J. C. Renauld, M. C. Fioretti, and P. Puccetti. 2000. IL-9 protects mice from Gram-negative bacterial shock: suppression of TNF-α, IL-12, and IFN-γ, and induction of IL-10. J. Immunol. 164:4197.